Skip to main content
SPT logo

SPT — Investor Relations & Filings

Ticker · 1789 ISIN · TW0001789006 TW Manufacturing
Open in API
Filings indexed 2,231 across all filing types
Latest filing 2023-11-09 Audit Report / Informat…
Country TW Taiwan
Listing TW 1789

About SPT

https://www.scinopharm.com/tw

ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.

Recent filings

Filing Released Lang Actions
112年第3季財務報告書 — 202304_1789_AIC.pdf
Audit Report / Information Classification · 100% confidence The document is titled 'PARENT COMPANY ONLY FINANCIAL STATEMENTS AND INDEPENDENT AUDITORS’ REPORT' for the years ended December 31, 2023 and 2022. It contains an independent auditor's opinion, detailed audit scope, key audit matters, and extensive financial statements including balance sheets and notes. The presence of an auditor's report and full financial statements indicates this is a standalone audit report rather than a full annual report or a brief announcement. The document is about 15,000 characters long, which is substantial and consistent with a detailed audit report. There is no indication that this is a certification letter or a report publication announcement. Therefore, the document fits the definition of an Audit Report / Information (AR).
2023-11-09 Chinese
112年第3季財務報告書 — 202304_1789_AIA.pdf
Annual Report Classification · 100% confidence The document is titled 'Consolidated Financial Statements and Independent Auditors’ Report' for the years ended December 31, 2023 and 2022. It includes detailed auditor opinions, key audit matters, management responsibilities, and audit procedures. The content is comprehensive, covering consolidated balance sheets, income statements, cash flows, and notes to the financial statements. The presence of an independent auditor's report and detailed financial statements indicates this is a full annual financial report. The document length is 15,000 characters, which is consistent with a full report rather than a brief announcement or certification. Therefore, this document fits the definition of an Annual Report (10-K) rather than a standalone audit report or announcement.
2023-11-09 Chinese
112年第3季財務報告書 — 202304_1789_AI3.pdf
Annual Report Classification · 100% confidence The document is titled as an individual financial report and auditor's report for the fiscal years 111 and 112 (Taiwan calendar years), which correspond to a full annual period. It contains detailed financial statements including balance sheets, income statements, statements of changes in equity, cash flow statements, and extensive notes on accounting policies and significant audit matters. The presence of an auditor's opinion and detailed financial data confirms this is a full annual financial report. The document is lengthy (15,000 characters) and contains substantive financial data, not merely an announcement or certification. Therefore, it fits the definition of an Annual Report (10-K).
2023-11-09 Chinese
112年第3季財務報告書 — 202304_1789_AI1.pdf
Audit Report / Information Classification · 95% confidence The document is titled as a consolidated financial report and auditor's report for Taiwan Shenlong Co., Ltd. and its subsidiaries for the fiscal years 112 and 111 (which correspond to 2023 and 2022 in the Gregorian calendar). It includes detailed consolidated financial statements such as the balance sheet, income statement, statement of changes in equity, cash flow statement, and notes to the financial statements. It also contains the auditor's opinion and key audit matters, indicating a full audit report is included. The document length is about 15,000 characters, which is consistent with a full annual report or audit report. The presence of the auditor's report and detailed financial statements suggests this is not just an announcement or a certification but the actual audited financial report. Given the content and structure, this document fits the definition of an Audit Report / Information (AR) rather than a full Annual Report (10-K), which typically includes more narrative management discussion and other sections. Therefore, the classification is AR with high confidence.
2023-11-09 Chinese
112年第3季財務報告書 — 202303_1789_AIA.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'CONSOLIDATED FINANCIAL STATEMENTS AND INDEPENDENT AUDITORS’ REVIEW REPORT SEPTEMBER 30, 2023 AND 2022' for ScinoPharm Taiwan, Ltd. It includes detailed consolidated balance sheets, statements of comprehensive income, cash flows, and notes. The report is prepared in accordance with International Accounting Standard 34, 'Interim Financial Reporting', and covers the three-month and nine-month periods ended September 30, 2023 and 2022. The presence of detailed financial statements and the auditor's review report for interim periods indicates this is a comprehensive interim financial report rather than a full annual report or just an audit report. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2023-11-09 Chinese
112年第3季財務報告書 — 202303_1789_AI1.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled as a consolidated financial report and accountant's review report for Taiwan Shenlong Co., Ltd. and its subsidiaries for the third quarter of years 112 and 111 (Taiwanese calendar years). It includes detailed consolidated financial statements such as balance sheets, income statements, statements of changes in equity, cash flow statements, and notes to the financial statements. The presence of an accountant's review report (核閱報告) indicates it is a reviewed interim financial report rather than a full annual report. The report covers a period shorter than a full fiscal year (quarterly/third quarter). The document is about 15,000 characters long and contains substantive financial data and analysis, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2023-11-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.